BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35944343)

  • 1. Harmonization of SARS-CoV-2 reverse transcription quantitative PCR tests to the first WHO international standard for SARS-CoV-2 RNA.
    Sahoo MK; Huang C; Sibai M; Solis D; Pinsky BA
    J Clin Virol; 2022 Sep; 154():105242. PubMed ID: 35944343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.
    Park J; Kim SY; Lee J; Hong KH
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of digital PCR to determine the reliability of Xpert Xpress SARS-CoV-2 assay with envelope (E) gene negative and nucleocapsid (N2) gene positive results.
    Wong RC; Wong AH; Ho YI; Siu GK; Lee LK; Leung EC; Lai RW
    Diagn Microbiol Infect Dis; 2022 Aug; 103(4):115726. PubMed ID: 35691105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Positive/Inconclusive Xpert Xpress SARS-CoV-2 with the Standard M nCoV Real-Time Detection.
    Oh AC; Kim H; Lee JK; Hong YJ
    Clin Lab; 2023 Oct; 69(10):. PubMed ID: 37844037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of SARS-CoV-2 Cycle Threshold Values: Multisite Investigation Evaluating Viral Quantitation across Multiple Commercial COVID-19 Detection Platforms.
    Gavina K; Franco LC; Robinson CM; Hymas W; Lei GS; Sinclair W; Hall T; Carlquist J; Lavik JP; Emery CL; Heaton PR; Hillyard D; Lopransi BK; Relich RF
    Microbiol Spectr; 2023 Feb; 11(1):e0447022. PubMed ID: 36651781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
    Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
    J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant.
    Choi H; Hwang M; Lukey J; Jinadatha C; Navarathna DH
    Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115699. PubMed ID: 35569431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR).
    Rawat P; Zerbato JM; Rhodes A; Chiu C; Tran T; Rasmussen TA; Druce J; Lewin SR; Roche M
    Pathology; 2022 Aug; 54(5):623-628. PubMed ID: 35778288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection.
    Chang-Graham AL; Sahoo MK; Huang C; Solis D; Sibai M; August G; Calayag L; Kenji OM; Shi RZ; Mostafa HH; Lei GS; Relich RF; Pinsky BA
    J Clin Virol; 2023 Jul; 164():105468. PubMed ID: 37119583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Commercially Available and Laboratory-Developed Assays for
    Lieberman JA; Pepper G; Naccache SN; Huang ML; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32350048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    Lee J; Song JU
    J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs.
    Relich RF; Van Benten K; Lei G-S; Robinson CM; Carozza M; Sahoo MK; Huang C; Solis D; Sibai M; Myers CA; Sikorski C; Balagot C; Yang D; Pinsky BA; Loeffelholz MJ
    Microbiol Spectr; 2024 Apr; 12(4):e0390823. PubMed ID: 38466093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Implementation of Improved SARS-CoV-2 Diagnostic Assays To Mitigate the Impact of Genomic Mutations on Target Failure: the Xpert Xpress SARS-CoV-2 Experience.
    Burns BL; Moody D; Tu ZJ; Nakitandwe J; Brock JE; Bosler D; Mitchell SL; Loeffelholz MJ; Rhoads DD
    Microbiol Spectr; 2022 Dec; 10(6):e0135522. PubMed ID: 36255326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
    Achenbach CJ; Caputo M; Hawkins C; Balmert LC; Qi C; Odorisio J; Dembele E; Jackson A; Abbas H; Frediani JK; Levy JM; Rebolledo PA; Kempker RR; Esper AM; Lam WA; Martin GS; Murphy RL
    PLoS One; 2022; 17(6):e0270060. PubMed ID: 35709204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
    Stevens B; Hogan CA; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
    J Appl Lab Med; 2020 Nov; 5(6):1307-1312. PubMed ID: 32761092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of automated molecular tests for the detection of SARS-CoV-2 in pooled nasopharyngeal and saliva specimens.
    Al-Hail H; Mirza F; Al Hashemi A; Ahmad MN; Iqbal M; Tang P; Hasan MR
    J Clin Lab Anal; 2021 Aug; 35(8):e23876. PubMed ID: 34132419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.